<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03847142</url>
  </required_header>
  <id_info>
    <org_study_id>2018-9027</org_study_id>
    <secondary_id>R18HS025645</secondary_id>
    <nct_id>NCT03847142</nct_id>
  </id_info>
  <brief_title>An Asthma Mobile Intervention to Promote Patient-Reported Outcomes in Primary Care</brief_title>
  <official_title>Adapting, Scaling, and Spreading an Algorithmic Asthma Mobile Intervention to Promote Patient-Reported Outcomes Within Primary Care Settings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Through this study, the investigators will adapt the ASTHMAXcel mobile app and evaluate the
      adapted intervention through a randomized controlled trial.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Through this study, the investigators will use patient and provider feedback to adapt the
      ASTHMAXcel mobile intervention, and will conduct a randomized controlled trial to test the
      intervention's impact on clinical and process outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Through the randomized controlled trial component, there will be 2 arms, which include the ASTHMAXcel intervention and usual care delivered through the outpatient primary care setting.</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline asthma quality of life to 2, 6, and 12 months</measure>
    <time_frame>Baseline, 2 months, 6 months, 12 months</time_frame>
    <description>Patients' asthma quality of life measured by the mini-Asthma Quality of Life Questionnaire (mini-AQLQ)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction measured by the Client Satisfaction Questionnaire-8</measure>
    <time_frame>Baseline, 2 months, 6 months, 12 months</time_frame>
    <description>Patient satisfaction measured by the Client Satisfaction Questionnaire-8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Provider perception of self-performance measured by the Asthma Physicians' Practice Assessment Questionnaire</measure>
    <time_frame>Baseline, 2 months, 6 months, 12 months</time_frame>
    <description>Provider perception of self-performance measured by the Asthma Physicians' Practice Assessment Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline asthma knowledge to 2 months, 6 months, and 12 months</measure>
    <time_frame>Baseline, 2 months, 6 months, 12 months</time_frame>
    <description>Asthma knowledge as measured by the validated KASE asthma questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient acceptance of ASTHMAXcel intervention as measured by the UTAUT questionnaire</measure>
    <time_frame>Baseline, 2 months, 6 months, 12 months</time_frame>
    <description>Patient acceptance of ASTHMAXcel intervention as measured by the UTAUT questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline asthma control to 2, 6, and 12 months</measure>
    <time_frame>Baseline, 2 months, 6 months, 12 months</time_frame>
    <description>Asthma symptom burden as measured by the Asthma Control Test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression as measured by the Patient Health Questionnaire-9</measure>
    <time_frame>Baseline, 2 months, 6 months, 12 months</time_frame>
    <description>Depression as measured by the Patient Health Questionnaire-9</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of asthma emergency department visits</measure>
    <time_frame>Baseline, 2 months, 6 months, 12 months</time_frame>
    <description>Number of asthma emergency department visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of asthma hospitalizations</measure>
    <time_frame>Baseline, 2 months, 6 months, 12 months</time_frame>
    <description>Number of asthma hospitalizations</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>ASTHMAXcel arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The ASTHMAXcel arm represents the study intervention, which is a patient-facing mobile application for adult patients with asthma.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm represents usual care delivered in the outpatient primary care setting at the study sites.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ASTHMAXcel mobile application</intervention_name>
    <description>ASTHMAXcel is a mobile application (patient-facing) that delivers guideline-based asthma education.</description>
    <arm_group_label>ASTHMAXcel arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Outpatient primary care</intervention_name>
    <description>Usual care delivered through the outpatient primary care setting</description>
    <arm_group_label>Usual care arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        English-speaking individuals &gt;18 years with:

          1. persistent asthma(diagnosis made by a healthcare provider) on a daily controller
             medication

          2. able to give informed consent

          3. Smartphone (iOS or Android) access

        Exclusion Criteria:

          1. use of oral corticosteroids in the 2 weeks prior to the baseline visit

          2. pregnancy

          3. severe psychiatric or cognitive problems that would prohibit an individual from
             completing the protocol

          4. patients that previously received ASTHMAXcel
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sunit Jariwala</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sunit Jariwala, MD</last_name>
    <phone>8666338255</phone>
    <email>sjariwal@montefiore.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emine Cosar</last_name>
    <phone>8666338255</phone>
    <email>ecosar@montefiore.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunit Jariwala</last_name>
      <phone>866-633-8255</phone>
      <email>sjariwal@montefiore.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>February 15, 2019</study_first_submitted>
  <study_first_submitted_qc>February 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 20, 2019</study_first_posted>
  <last_update_submitted>December 16, 2019</last_update_submitted>
  <last_update_submitted_qc>December 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Sunit P. Jariwala</investigator_full_name>
    <investigator_title>Associate Professor (Medicine)</investigator_title>
  </responsible_party>
  <keyword>informatics</keyword>
  <keyword>asthma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

